文献速递主动脉疾病外周动脉疾病

Mas受体缺陷加重高胆固醇血症雄性小鼠血管紧张素II诱导的动脉粥样硬化与主动脉瘤破裂

Mas receptor deficiency augments angiotensin II-induced atherosclerosis and aortic aneurysm ruptures in hypercholesterolemic male mice.
PubMed 文献 · J Vasc Surg · 2019-03-06

本研究在高胆固醇血症雄性小鼠中探讨Mas受体(MasR)缺陷对血管紧张素II(AngII)诱导的动脉粥样硬化和腹主动脉瘤(AAA)的影响。结果表明,MasR缺陷不改变血压和胆固醇,但加重动脉粥样硬化、增大AAA直径并增加主动脉破裂,机制涉及氧化应激、炎症和凋亡增加。提示MasR激活可能对血管疾病有治疗作用。

要点

  • MasR缺陷加重AngII诱导的动脉粥样硬化(P<.05)。
  • MasR缺陷增大AAA直径并增加主动脉破裂(P<.05)。
  • 机制涉及氧化应激、炎症和凋亡增加。

核心结论

  • MasR缺陷通过增加氧化应激、炎症和凋亡加重AngII诱导的动脉粥样硬化和AAA破裂,提示MasR激活可能有治疗效益。

研究设计与样本

  • MasR+/+和MasR-/-雄性小鼠在Ldlr-/-或Apoe-/-背景下,通过渗透泵输注AngII 600或1000 ng/kg/min持续28天。

主要发现

  • MasR缺陷增加Ldlr-/-小鼠主动脉弓动脉粥样硬化病变面积百分比(P<.05)。
  • MasR缺陷增大Ldlr-/-和Apoe-/-小鼠AAA内径和外径并增加主动脉破裂(P<.05)。
  • MasR缺陷增加主动脉根部氧化应激和凋亡(P<.05)。
  • MasR缺陷增加腹主动脉弹性蛋白断裂及T淋巴细胞和巨噬细胞积累(P<.05)。
  • MasR缺陷不影响体重、基线及AngII输注期间收缩压和血清胆固醇浓度。

临床怎么用

  • MasR激活可能作为治疗动脉粥样硬化和AAA的潜在靶点,但需进一步临床研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Previous studies demonstrated that deficiency of angiotensin-converting enzyme 2 (ACE2) augmented angiotensin II (AngII)-induced atherosclerosis and abdominal aortic aneurysm (AAA) formation in hypercholesterolemic mice. Effects of ACE2 deficiency could arise from increased concentrations of its substrate, AngII, or decreased concentrations of its product, angiotensin-(1-7) [Ang-(1-7)]. Infusion of Ang-(1-7), a Mas receptor (MasR) ligand, to hypercholesterolemic male mice reduced AngII-induced atherosclerosis, suggesting a protective role of the Ang-(1-7)/MasR axis. However, it is unclear whether endogenous Ang-(1-7) acts at MasR to influence AngII-induced vascular diseases. The purpose of this study was to define the role of MasR deficiency in AngII-induced atherosclerosis and AAA formation and severity in hypercholesterolemic male mice. METHODS: MasR+/+ and MasR-/- male mice on a low-density lipoprotein receptor-deficient (Ldlr-/-) or apolipoprotein E-deficient (Apoe-/-) background were infused with AngII at either 600 or 1000 ng/kg/min by osmotic minipump for 28 days. Atherosclerosis was quantified at study end point as percentage lesion surface area of the aortic arch in Ldlr-/- mice. Abdominal aortic internal diameters were quantified by ultrasound, and maximal external AAA diameters were quantified at study end point. Blood pressure was quantified by radiotelemetry and a tail cuff-based technique. Serum cholesterol concentrations and vascular tissue characterization were examined at study end point. RESULTS: MasR deficiency did not influence body weight, systolic blood pressure at baseline and during AngII infusion, or serum cholesterol concentrations in either Apoe-/- or Ldlr-/- mice. MasR deficiency increased AngII-induced atherosclerosis in aortic arches of Ldlr-/- mice (P < .05), associated with increased oxidative stress and apoptosis in aortic root sections (P < .05). MasR deficiency also augmented internal and external AAA diameters and increased aortic ruptures of both Ldlr-/- and Apoe-/- mice (P < .05). These effects were associated with increased elastin breaks and T-lymphocyte and macrophage accumulation into abdominal aortas of AngII-infused MasR-deficient mice (P < .05). CONCLUSIONS: These results demonstrate that MasR deficiency augmented AngII-induced atherosclerosis and AAA rupture through mechanisms involving increased oxidative stress, inflammation, and apoptosis, suggesting that MasR activation may provide therapeutic efficacy against vascular diseases.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Stegbauer J, Thatcher SE, Yang G, et al. Mas receptor deficiency augments angiotensin II-induced atherosclerosis and aortic aneurysm ruptures in hypercholesterolemic male mice. J Vasc Surg. 2019. PMID: 30850299. doi:10.1016/j.jvs.2018.11.045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。